Status:
WITHDRAWN
Clinical Outcomes of Patients Implanted With the RxSight Light Adjustable Lens (LAL)
Lead Sponsor:
Vance Thompson Vision
Conditions:
Cataract
Pseudophakia
Eligibility:
All Genders
40-80 years
Brief Summary
The objective of this investigator initiated study (IIT-002) is to collect data on commercial patients implanted with the RxSight Light Adjustable Lens (LAL).
Eligibility Criteria
Inclusion
- Sign a written Informed Consent Document
- Implanted commercially with the LAL and completed LDD light treatments
Exclusion
- Previous corneal or intraocular surgery other than removal of cataract and implantation of the LAL
Key Trial Info
Start Date :
August 13 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06488066
Start Date
August 13 2021
End Date
January 1 2022
Last Update
July 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vance Thompson Vision
Sioux Falls, South Dakota, United States, 57108